Vicore Pharma Holding AB (publ) (VCRE)

Vicore Pharma Holding AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	377.42	578.15	1,156	333.62	256.8	294.2
Short-Term Investments	682.37	588.59	-	149.15	4.94	77.28
Cash & Short-Term Investments	1,060	1,167	1,156	482.77	261.74	371.48
Cash Growth	1.05%	0.93%	139.45%	84.44%	-29.54%	16.55%
Other Receivables	4.1	16.24	19.76	3.13	2.18	1.42
Receivables	4.1	16.24	19.76	3.13	2.18	1.42
Prepaid Expenses	10.36	33.94	19.82	9.7	5.87	5.03
Total Current Assets	1,074	1,217	1,196	495.6	269.79	377.93
Property, Plant & Equipment	-	-	-	0.03	0.12	0.4
Long-Term Investments	-	-	-	-	-	5.41
Other Intangible Assets	-	-	-	2.22	68.1	67.43
Other Long-Term Assets	3.02	1.71	-	-	-	-
Total Assets	1,077	1,219	1,196	497.84	338.01	451.17

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	34.1	39.47	29.97	17.92	23.5	23.98
Accrued Expenses	48.11	65.8	15.75	14.65	18.22	40.14
Current Portion of Leases	-	-	-	-	0.07	-
Current Income Taxes Payable	-	0.06	1.93	1.13	0.76	0.34
Other Current Liabilities	2.46	13.1	18.04	7.27	3.88	1.26
Total Current Liabilities	84.66	118.43	65.69	40.96	46.42	65.72
Long-Term Leases	-	-	-	-	-	0.32
Long-Term Deferred Tax Liabilities	-	-	-	0.59	0.91	1.21
Other Long-Term Liabilities	1.69	4.74	0.56	0.9	1.6	0.6
Total Liabilities	86.35	123.18	66.25	42.45	48.92	67.85

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	140.76	140.76	117.29	55.86	40.92	35.88
Additional Paid-In Capital	-	2,876	2,454	1,674	1,211	1,022
Retained Earnings	-	-1,921	-1,442	-1,274	-962.65	-674.23
Comprehensive Income & Other	850.15	-	-	-	-	-
Shareholders' Equity	990.91	1,095	1,129	455.39	289.08	383.32
Total Liabilities & Equity	1,077	1,219	1,196	497.84	338.01	451.17

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	-	-	-	-	0.07	0.32
Net Cash (Debt)	1,060	1,167	1,156	482.77	261.68	371.16
Net Cash Growth	1.05%	0.93%	139.45%	84.49%	-29.50%	16.50%
Net Cash Per Share	4.21	4.86	8.45	5.00	3.62	5.33
Filing Date Shares Outstanding	281.53	281.53	234.58	111.72	81.85	71.76
Total Common Shares Outstanding	281.53	281.53	234.58	111.72	81.85	71.76
Working Capital	989.59	1,098	1,130	454.64	223.37	312.21
Book Value Per Share	3.52	3.89	4.81	4.08	3.53	5.34
Tangible Book Value	990.91	1,095	1,129	453.17	220.98	315.89
Tangible Book Value Per Share	3.52	3.89	4.81	4.06	2.70	4.40
Machinery	-	-	-	0.15	0.15	0.15

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 17, 2026

Data Sources Report a data error